Enhancing Antitumor Efficacy of Nucleoside Analog 5-Fluorodeoxyuridine on HER2-Overexpressing Breast Cancer by Affibody-Engineered DNA Nanoparticle

BACKGROUND: Chemotherapy, as an adjuvant treatment strategy for HER2-positive breast cancer, can effectively improve clinical symptoms and overcome the drug resistance of therapeutic monoclonal antibodies. Nucleoside analogues are a class of traditional chemotherapeutic drugs that are widely applied...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chao, Han, Mengnan, Zhang, Fanghua, Yang, Xueli, Du, Jie, Zhang, Honglei, Li, Wei, Chen, Shengxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020921/
https://www.ncbi.nlm.nih.gov/pubmed/32103944
http://dx.doi.org/10.2147/IJN.S231144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020921/
https://www.ncbi.nlm.nih.gov/pubmed/32103944
http://dx.doi.org/10.2147/IJN.S231144

Ejemplares similares